The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Systematic review and meta-analysis of post-progression outcomes in ER+/HER2- metastatic breast cancer after treatment with endocrine therapy and CDK 4/6 inhibitors within randomized clinical trials.
 
Elisabetta Munzone
Consulting or Advisory Role - Eisai; Genomic Health; Pierre Fabre
Travel, Accommodations, Expenses - Celgene; Eisai; Mylan; Pfizer; Roche
 
Eleonora Pagan
No Relationships to Disclose
 
Vincenzo Bagnardi
No Relationships to Disclose
 
Emilia Montagna
Consulting or Advisory Role - Pierre Fabre
 
Giuseppe Cancello
Consulting or Advisory Role - Pierre Fabre
 
Silvia Dellapasqua
No Relationships to Disclose
 
Monica Iorfida
Consulting or Advisory Role - Lilly; Novartis
 
Manuelita Mazza
No Relationships to Disclose
 
Marco Colleoni
Research Funding - Roche (Inst)